Both in Pharmaceuticals
Lyell Immunopharma vs Atea Pharmaceuticals
Over the past year LYEL returned −3.3% and AVIR returned +38.9%; their daily moves had a correlation of 0.23.
LYEL −3.3% AVIR +38.9%Growth of $1, one year, split-adjusted
| Metric | LYEL | AVIR |
|---|---|---|
| Price | $15.43 | $4.46 |
| Market cap | $378.1M | $357.7M |
| Today | +43.27% | +6.95% |
| 1 month | +79.2% | −12.0% |
| 6 months | −26.0% | −21.1% |
| Year to date | −49.9% | +24.9% |
| 1 year | −6.8% | +37.2% |
| Revenue growth (YoY) | −50.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −1118875.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 14,004.2× | — |
| Net cash | $204.1M | $219.5M |
| Dividend yield | — | — |
| Volatility (60d) | 101.1% | 46.6% |
| Short % of float | 15.8% | 5.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).